Status:
RECRUITING
Decision Aid (DA) for Renal Patients
Lead Sponsor:
NYU Langone Health
Conditions:
Kidney Tumor
Renal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team...
Eligibility Criteria
Inclusion
- Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
- Patients scheduled for standard-of-care clinical exams with the NYU Urology Department
Exclusion
- Stage IV cancer of any type
- Inability to provide informed consent
- Vulnerable subjects will not be recruited
Key Trial Info
Start Date :
September 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05387863
Start Date
September 12 2022
End Date
September 1 2026
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016